Our Brands

Bio-Rad CSD

Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for 70 years, our products advance the discovery process and improve healthcare. Our customers include university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality.

Discover our range of products to best fits your application needs.

Clinical System Division (CSD)

For over 30 years, Bio-Rad has been at the forefront in developing the world's most accurate and precise diabetes testing products. Today, Bio-Rad offers a full range of innovative HbA1c products for clinical and hospital laboratories. All Bio-Rad diabetes products are NGSP (National Glycohemoglobin Standardization Program) certified and IFCC aligned. D-10 Hemoglobin Testing System Bio-Rad D-10 Hemoglobin Testing System offers HbA1c testing and β-thalassemia testing in a compact system. Reagents are ready to use that aids physician’s diagnosis of prediabetes & diabtes. VARIANT II Turbo Hemoglobin Testing System / D-100 Hemoglobin Testing System With higher workload, Variant II Turbo and D-100 Hemoglobin Testing System offers HbA1c testing as easy as A-1-c VARIANT II Hemoglobin Testing System Bio-Rad VARIANT II Hemoglobin Testing System offers HbA1c testing and β-thalassemia testing in a fully automated platform. β-thalassemia testing reagents are ready to use provides HbA2 and HbF percentage to aid in screening and detects the most commonly occurring abnormal haemoglobin variants. VARIANTnbs Newborn Hemoglobin Screening System The VARIANTnbs Hemoglobin Testing System tests newborn dried blood specimens for abnormal hemoglobins associated with sickle cell disease and other hemoglobin disorders. The VARIANTnbs is specifically designed for high-capacity screening and walk-away automation, reducing labor requirements and human errors.commonly occurring abnormal haemoglobin variants.

Can’t find what you’re looking for?

Contact us